Moving Medicine Forward

In this episode, host Jeremy Schrand welcomes Tim Schroeder, Founder & CEO of CTI, Jaqueline Aguiar, Managing Director of APAC/LATAM, and Dr. Ludwig Baumann, Global Regulatory Strategist, for an in-depth conversation about the Asia Pacific region’s growing impact on clinical research. Together, they explore how population diversity, regulatory innovation, and advanced therapies are shaping the...

In this episode, host Jeremy Schrand welcomes Jamie Glavic, Senior Manager, Corporate Communications & Community Engagement and Program Lead of CTI Cares, and Kirsten Wellige, Associate Director, Clinical Project Coordination and Global Chair of the EU CTI Cares Committee, to discuss CTI Cares, CTI’s global employee-driven program that brings company values to life through community engagement...

We are joined by two leaders from Aminex Therapeutics, Mark Burns, President & CSO, and Jeff Judson, VP of Strategic Planning & Investor Relations, to discuss the groundbreaking development of Aminex 1501, a novel cancer therapy that is transforming oncology. This conversation dives into the science behind this innovative therapy, its distinctive funding journey, the promising clinical tri...

In this special year-end episode of Moving Medicine Forward , host Jeremy Schrand sits down with CTI’s founder and CEO Tim Schroeder and President & COO Jon Koch for an in-depth look at 2025. From strategic goals and operational breakthroughs to cultural pillars and global challenges, Tim and Jon share candid insights on what made this year transformative for CTI. They also discuss major clini...

Courtney Cordaro, Director and Therapeutic Strategy & Innovation Lead at CTI, discusses the rapidly changing landscape of hematology clinical research. She shares insights on operational excellence and innovation, demonstrating why adaptability and precision are key to success in hematology clinical trials.  01:00  Courtney shares her background and passions.  02:29  The growing need for rapid...

Recorded live at American Society of Nephrology’s Kidney Week 2025, this episode of Moving Medicine Forward features Courtney Cordaro, Director of Therapeutic Strategy at CTI, and Morgan Terry, Site Director at Eastern Nephrology Associates. Together, they discuss what drives a healthy and productive partnership between clinical research sites and CROs, the critical role of communication, and how...

In this inspiring episode of Moving Medicine Forward ,Amanda King, Senior Clinical Scientist at CTI, discusses her remarkable journey from pediatric ICU nurse practitioner to leading-edge oncology researcher. Amanda shares how personal loss fueled her passion for patient-centered careand clinical research, and how her work at the NIH and CTI is shaping the future of medicine. From the complexities...

Joel White, Owner of Marketcap Consulting, joins another episode to discuss the evolving role of Clinical Research Organizations (CROs). He shares the characteristics of a great CRO, how technology and decentralization are shaping the industry, and the strategic balance between speed, quality, and cost in clinical trials. Whether you're a sponsor, CRO professional, or simply curious about the...

Chuck Scheper, Board Chair at Bexion Pharmaceuticals, shares how a stage IV non-Hodgkin lymphoma diagnosis at age 39 and a life-saving clinical trial led to his lifelong commitment to cancer research. He joins Tim Schroeder, CEO and Chairman of CTI, to discuss the founding of VaxCella, the evolution of cancer therapies, the importance of patient-centered research, and the role of collaboration in...

In this episode, host Jeremy Schrand is joined by Tim Schroeder, Chairman, CEO, and Founder of CTI, and Joel White, Owner of Marketcap Consulting, for a broad discussion on the clinical research industry. Topics include recent industry developments, biotech funding challenges, leadership in clinical trials, corporate citizenship, and predictions for future innovation. 01:20 Tim shares insights on...

In this special episode, host Jeremy Schrand sits down with Jill Brinck, Executive Director of CancerFree KIDS, and Dr. Genevieve Kendall, a CancerFree KIDS grant recipient and pediatric cancer researcher at Baylor College of Medicine.  Together, they explore the power of early-stage research funding, the challenges and breakthroughs in treating childhood cancers, and the inspiring mission behind...

In this episode of Moving Medicine Forward , host Jeremy Schrand welcomes Dr. Rich Curry to discuss how CTI is helping redefine what’s possible in clinical research. From the complexities of cell and gene therapy to the human stories behind the science, Dr. Curry shares how CTI’s expertise in rare diseases and regenerative medicine is accelerating innovation and improving patient outcomes. Discove...

In this episode of “Moving Medicine Forward,” SavannahDoliboa, Chief Commercial Officer at CTI, shares her career journey and what led her to CTI, a company that combines the strengths of both large and mid-sized CROs. She reflects on the rewards of working with rare disease sponsors, CTI’s diverse client base, and its reputation for flexibility, expertise, and lasting partnerships. Savannah also...

In this episode of “Moving Medicine Forward,” Audrey Davidow shares how her son’s diagnosis led to her co-founding the Pitt Hopkins Research Foundation. She explains the rare genetic disorder, the foundation’s focus on research and family support, and major breakthroughs such as a gene therapy trial. Audrey also reflects on advocacy, leadership challenges, and the hope driving their mission forwar...

Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials. Topics Covered: CTI’s history and expansion in...

In this episode of “Moving Medicine Forward,” Tara Mink,expert in cell and gene therapy for more than 25 years, joins to discuss the science, promise, and challenges of CAR-T therapy. Tara explains how CAR-T works, its remarkable durability, and the side effects clinicians manage. She also discusses the future of gene therapy, barriers to access, and how the field is expanding into new disease are...

In this episode of “Moving Medicine Forward,” host Jeremy Strand sits down with Brian Lawrence, Chief Financial Officer at CTI, to explore how strategic financial planning is critical to advancing clinical trials, particularly in rare disease research. Brian shares insights on balancing profitability with purpose in one of the world’s most highly regulated industries, reflecting on early career de...

What makes a clinical trial site successful when managing complex transplant studies? In this episode of “Moving Medicine Forward,” host Jeremy Schrand is joined by Shawna Bredek, a 20+ year veteran in clinical trial operations, to explore how feasibility assessments shape the future of life-saving research. Shawna shares how her team evaluates sites, navigates post-COVID challenges, tackles regul...

In this episode of Moving Medicine Forward, we sit down with Dr. Helios Tedesco, a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world’s largest kidney transplant programs. Joined by CTI experts Dr. Christopher Boshkos, Senior Medical Director, and Clinical Scientist, Erika Aldag, the conversation explores the challenges and innovations behind managing mo...

In this episode of “Moving Medicine Forward” – The Podcast, Jamie Meisenhelder, Chief Administrative Officer (CAO) at CTI, joins us to reflect on her unique journey from law to leadership and how she oversees CTI’s legal, QA, and administrative functions. She shares how her team supports clinical trials, tackles global regulatory challenges, maintains quality standards, and keeps patient trust as...

In this episode, Jeremy sits down with Sara Russo and John Mock from Network for Hope, an independent nonprofit organ procurement organization. Together, they explore the life-changing work of organ and tissue donation — from the hospital bedside to the recipient's second chance at life.    Learn how the organization evolved from a merger between LifeCenter and KODA, now serving 7 million peop...

In this episode of “Moving Medicine Forward” – The Podcast, Monica Rodriguez, Managing Director of Global Laboratory, Pharmacometrics, and Site Services at CTI, and Andy Supp, Vice President of Global Laboratory Services at CTI, join the conversation to discuss the unique structure and capabilities of CTI’s global laboratories. They share insights into their respective backgrounds, the strategic i...

In this episode of “Moving Medicine Forward” – The Podcast, Pat Dearing, Chief Human Resources Officer at CTI, discusses his career journey and the unique challenges of HR in healthcare. He shares insights on recruiting top talent, "people-first leadership," and CTI's DEIB council. Pat also talks about the future of remote work, HR’s role in acquisitions, and emerging trends shaping the future of...

In this episode of “Moving Medicine Forward” – The Podcast, Christine Eby, Director of Clinical Project Management & Therapeutic Strategy Lead at CTI, Anna Sowa, Chief Mission Officer at CurePDE, Curtis R. Coughlin II, PhD, MS, MBE, Associate Professor, Department of Pediatrics and Center for Bioethics and Humanities, and Kristy McCay, mom of a two-year-old living with pyridoxine-dependent epi...

In this episode of "Moving Medicine Forward" – The Podcast, Jill Black, Validation IT Principal Auditor at CTI, shares the deeply personal story of her daughter, Emma, and their journey navigating this rare disease. She offers valuable insights into the challenges and impact of Rett Syndrome, while discussing her work at CTI and how being part of an organization focused on rare diseases...